miR‐218 contributes to drug resistance in multiple myeloma via targeting LRRC28.

Autor: Chen, Haifei, Cao, Weiling, Chen, Jiao, Liu, Danbo, Zhou, Lingyun, Du, Fang, Zhu, Feiqi
Zdroj: Journal of Cellular Biochemistry; Apr2021, Vol. 122 Issue 3/4, p305-314, 10p
Databáze: Complementary Index
Externí odkaz: